Robert James Wills - Apr 8, 2024 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Apr 8, 2024
Transactions value $
$27,655
Form type
4
Date filed
4/10/2024, 08:38 PM
Previous filing
Apr 1, 2024
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $27.7K +3.09K +44.63% $8.96 10K Apr 8, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, but the reporting person previously paid the Issuer the full amount of the profit realized in connection with the short swing transaction. No further amounts are required to be disgorged.
F2 The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.76 to $9.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.